Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Genes
|
July 27, 2022
Impact of Chromosomal Context on Origin Selection and the Replication Program
Lilian Lanteri, Anthony Perrot, Diane Schausi-Tiffoche, et al.
Plos Genetics
|
February 22, 2018
CDK activity provides temporal and quantitative cues for organizing genome duplication
Anthony Perrot, Christopher Lee Millington, Blanca Gómez-Escoda, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
November 17, 2012
Toward libraries of biotinylated chondroitin sulfate analogues: from synthesis to in vivo studies
Guillaume Despras, Clémence Bernard, Anthony Perrot, et al.
Nature Communications
|
November 16, 2018
Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma
Sébastien Corre, Nina Tardif, Nicolas Mouchet, et al.
Clinics and Research in Hepatology and Gastroenterology
|
February 21, 2022
MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer
Emeric Boisteau, Alexandra Lespagnol, Marie De Tayrac, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Genes
|
July 27, 2022
Impact of Chromosomal Context on Origin Selection and the Replication Program
Lilian Lanteri, Anthony Perrot, Diane Schausi-Tiffoche, et al.
Plos Genetics
|
February 22, 2018
CDK activity provides temporal and quantitative cues for organizing genome duplication
Anthony Perrot, Christopher Lee Millington, Blanca Gómez-Escoda, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
November 17, 2012
Toward libraries of biotinylated chondroitin sulfate analogues: from synthesis to in vivo studies
Guillaume Despras, Clémence Bernard, Anthony Perrot, et al.
Nature Communications
|
November 16, 2018
Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma
Sébastien Corre, Nina Tardif, Nicolas Mouchet, et al.
Clinics and Research in Hepatology and Gastroenterology
|
February 21, 2022
MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer
Emeric Boisteau, Alexandra Lespagnol, Marie De Tayrac, et al.
Page
of 1